• FRSX’s QuadSight™ multi-camera vision solution is a stereoscopic system that detects obstacles in all weather and lighting conditions designed for semi-autonomous and autonomous vehicles
• In its corporate presentation, FRSX cites projection of the autonomous self-driving vehicle market reaching $60 billion by 2030, from Mordor Intelligence LLP
• FRSX has in development its Eyes-On™ and Eye-Net™ patent-pending accident prevention solutions

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), in an audio press release, detailed the advantages of its passive sensor vision system versus active ones. As sensors will play a key role in the development of self-driving vehicles, FRSX’s QuadSight™ passive sensor system uses available light for its visible light cameras and thermal radiation of objects for its infrared cameras (http://ibn.fm/8IIJU).

FRSX’s stereoscopic technology leverages the advantages of passive sensors rather than active systems. It employs two synchronized cameras to mimic 3D human depth perception. In contrast, active sensors emit energy that may interfere with others, resulting in the possibility of some objects going undetected. QuadSight does not rely on pattern recognition. Rather, it is a passive stereo vision system that uses advanced image processing algorithms for accurate depth analysis and detects objects from available light and thermal radiation caught by its infrared cameras.

Israel-based FRSX, through wholly owned subsidiary Foresight Automotive, is designing, developing and commercializing advanced driver assistance systems (ADAS) for use in semi-autonomous and autonomous vehicles. It is developing several branded and patent-pending systems. Proprietary systems include Eyes-On™, an advanced ADAS system, and Eye-Net™, a cellular-based V2X accident prevention alert solution.

In its corporate presentation, the company documented that the stakes are high (http://ibn.fm/o0efI). FRSX sees a long-term market potential for autonomous vehicles that’s projected at $60 billion by 2030, according to Mordor Intelligence LLP (http://ibn.fm/Imu0J).

In a news release, Haim Siboni, CEO of FRSX, said, “At Foresight, we believe that a car’s vision system should be nothing less than perfect. Vision is the foundation of passenger safety, and vision perfection under all weather and lighting conditions is clearly the breakthrough that vehicle makers need to build consumer confidence in order to accelerate autonomous vehicle adoption.”

For more information, visit the company’s website at www.ForesightAuto.com

• CEO John ‘JT’ Thatch says that SHRV’s all-time high gross sales in April were directly impacted by the success of its Elevacity Global line, which includes vitamin patches, anti-aging mud and skincare products
• Record April revenues continue SHRV’s momentum; company sales of $2.4 million in March doubled that of the prior month
• SHRV eyes future growth and believes that it will be well-supported by partnering with more providers, according to Chairman Robert Oblon

Sharing Services, Inc.’s (OTC: SHRV) sales momentum continues after it reported record revenue of more than $3.5 million for April. This follows its $2.4 million in gross sales in March, which doubled its total volume for February. SHRV stressed that major contributors in April were the Elevacity health-and-wellness division product line, together with the execution by its Elepreneurs marketing team of its unique Blue Ocean strategy and direct-to-market approach (http://ibn.fm/Yxm06).

Elevacity Global’s wellness products include anti-aging Elier Mud, vitamin patches designed to generate energy and the Timeless line of skincare products for men and women. John ‘JT’ Thatch, CEO of Sharing Services, said in a news release that SHRV’s customers “seem very pleased” and are “seeing great results” with the line’s products.

SHRV is a Plano, Texas-based diversified holding company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services such as energy, technology and insurance.

The company’s go-to-market strategy is defined as focusing on the end-user and connecting with potential clients. Blue Ocean selling is a concept of marketing in an uncontested marketplace. Execution of those methods resulted in record sales in March (http://ibn.fm/EcpaO).

Robert Oblon, chairman of SHRV, said that the company would grow in the future by partnering with more providers. To that end, Sharing Services recently completed a joint venture agreement with Hong Kong-based Health Wealth & Happiness Ltd. (“HWH”) to sell its products throughout Asia and expand its Elepreneur program (http://ibn.fm/RQlyT).

Oblon added, “Since the company launched late last year, it has taken several steps to support its pursuit of expansion, including establishing a new corporate headquarters to accommodate growth as well as bringing on experienced talent. These steps, among others, have also helped drive the company forward while momentum builds on a grand scale.”

For more information, visit the company’s website at www.SharingServicesInc.com

• Smoking as a delivery method faces increasing stigma
• Vaporization set to be a major smoking alternative
• Sunniva signs contract to supply extraction services to award winning cannabis brand

Heightened awareness of the dangers posed by smoking is shaping the fast-developing cannabis marketplace. Smoking, the delivery vehicle of the tobacco industry, is playing a much lesser role.

Nicotine may not kill – indeed, it is thought to have some health benefits – but smoking will. So, as markets for adult recreational use of marijuana open up across the U.S., alternative delivery technologies are expected to take center stage. Particularly popular is vaporizing, which, apart from the potential health benefits it offers, avoids the unpleasant (to some) smell of tobacco smoke and, in the typical vape pen, offers an easy method of use. As a result, the market for vaporizers is expected to rise rapidly. Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is set to float on that rising vaporizer trend. The company recently announced that, through a wholly-owned subsidiary, it had secured an additional extraction contract with Cali Gold, a leading legacy California cannabis brand. Operating in the world’s two largest cannabis markets, Canada and California, Sunniva continues to pursue its vision of becoming the lowest cost, highest quality cannabis producer in the markets it serves.

There’s no doubt that vaping, once an esoteric activity with which few were familiar, is going to play an important role as medical and recreational markets for cannabis develop. According to one analyst, the vaporizer market in the states of California, Colorado, Oregon and Washington grew 57.7 percent during 2017, reaching $1.84 billion by year-end (http://ibn.fm/54QIo). Sunniva is already in position to benefit from those market developments. Its contract with Cali Gold gives it a ticket to ride the rising vaporization trend for, at least, the next 12 months, and the agreement may be renewed for a further 12-month term, if Cali Gold so desires.

Signed by wholly-owned subsidiary CP Logistics, LLC’s Sun-Oil Facility, the deal enables Sunniva to provide Cali Gold with high quality, ultra-purified manufactured distilled oil products to be utilized within vaporization cartridges (http://ibn.fm/CjSfI) and other delivery formats. Based in Berkeley, California, Cali Gold is a popular cannabis brand that has specialized in high quality edibles. The Cali Gold THCA Chocolate Bar was awarded first place in Edibles List Magazine. Cali Gold looks to Sunniva’s quality expertise at scale to introduce 10-15 new products in the next six months.

Sunniva’s Sun-Oil Facility is a state-of-the-art facility that, at full capacity, will be able to produce over 600,000 filled vaporization cartridges a month. Ideally suited to supply other white label marketers, like Cali Gold, the facility is licensed for both volatile and non-volatile extraction, which enables Sunniva to produce multiple forms of extracted products.

Sunniva’s Sun-Oil Facility is located about one mile from the Sunniva California Campus in Cathedral City, where it continues construction of a state-of-the-art cGMP-compliant greenhouse.  cGMP (current Good Manufacturing Practice) regulations are mandated by the U.S. Food and Drug Administration (FDA) to ensure proper design, monitoring and control of manufacturing processes and facilities. Phase 1 of the project involves the development of a 325,000 square foot greenhouse capable of producing 60,000 kilos per year of dry cannabis at capacity.  Approximately 30 percent of initial total production is earmarked for conversion to oils and extracts. Phase 2 is expected to increase the greenhouse by 164,000 square feet and increase production by some 40,000 kilos per year.

Further north, work continues at the Canada Campus, a 126-acre site at Okanagan Falls, British

Columbia. The 740,000 square foot facility will have an estimated output capacity of 100,000 kg annually and is expected to become operational in 2019, which will complement Sunniva’s other Canadian subsidiary, Natural Health Services (NHS). NHS, which owns and operates seven medical marijuana clinics in Canada, has a patient base of 95,000, which is served by 21 physicians. The Canadian market is just as likely to embrace vaporization, a delivery format that could make cannabis consumption much safer health wise than tobacco ever was.

For more information, visit the company’s website at www.sunniva.com

• An “alarm call” to the demands of an aging population and the increase of people living with dementia
• GPS SmartSole® technology used to predict wandering for individuals with dementia
• Announces strategic plan to uplist to the OTCQB Venture Exchange

The number of people living with dementia is soaring, and their families and caregivers are looking for solutions that allow their loved one’s greater independence.  According to the World Health Organization (WHO), the number of people affected by this debilitating condition will triple from 50 million to 152 million in the next 30 years. Dr. Tedros Adhanom Ghebreyesus, director-general of WHO, describes this increase as “an alarm call” that demands greater attention to ensure that those living with dementia receive the necessary care (http://ibn.fm/25Ec6).

GTX Corp (OTC: GTXO), a self-described ‘pioneer in loT wearable technology’, is working to provide solutions to this growing problem. The company’s patented GPS SmartSole® is a non-visible GPS tracking device designed to monitor the location of people who have a tendency to get lost or wander. Easily inserted into the loved one’s shoe, it provides the caregiver with peace of mind through continuous, real-time location coordinates rendered on a mapping system in the GTX Corp Monitoring Portal, which is accessible from any computer or smartphone. Location history, geozone boundary alerts and more are available to the caregiver. When the loved one goes outside of designated boundaries, the caregiver is alerted.

GTXO is committed to working with partners to develop innovative solutions for this large section of the aging population and recently announced that George Mason University’s (GMU) College of Health and Human Services has completed its phase II machine learning wandering prediction research. This research can be used to predict the likely location of individuals with dementia and detect movement outside of those patterns that suggest wandering.

“Many of those who wander will not even realize they are lost or may hide from those searching for them. So this is truly groundbreaking data that offers the potential to save lives and dramatically reduce the costs of high-resource rescue operations,” Andrew Carle, adjunct professor and founding director of the Program in Senior Housing Administration at GMU, stated in a news release (http://ibn.fm/jw4pf).

Addressing the needs of this growing population, GTXO is an approachable option for investors seeking to diversify into wearable technology. The company reported a solid first quarter and promising growth.

Revenues, subscribers, margins and profits are all up for the company, while the cost of operations, professional services, G&A expenses and net losses decreased. Also, GTXO completed the delivery of its first large-scale military contract and secured a strategic financial partner providing funds for continued capital growth throughout 2018 and 2019. Over the last several months GTXO’s board and management have been strategically working “to make the public side of the business more reflective of the positive milestones and forward progress achieved in recent months,” as noted by GTXO CEO Patrick Bertagna in the company’s announcement of plans to uplist to the OTCQB Venture Exchange.

GTXO plans to make several more announcements in the coming weeks as its management team strategically positions the company for the future.

For more information, visit the company’s website at www.GTXCorp.com

• Global helium market expected to exceed $1.5 billion by 2020, CAGR at 9%
• Tech driven demand for helium continues to surge across multiple industries including healthcare, military, R&D, space travel and electronics
• Management team with a track record of M&A success in the resource sector
• Company focused on becoming a developer and producer of quality helium resources in North America
• Clear path to production with a focused development plan to commercialize the company’s assets

American Helium Inc. (TSX.V: AHE) (OTCQB: AHELF) is a resource exploration company focused on the global growth of technology-driven demand for helium and the development of high grade helium resources in North America. Through such activities, it strives to contribute to the global helium inventory and become an industry leading producer.

The Canadian helium exploration and development company is led by an experienced management and technical team. The Company is currently focused on three properties in prolific areas for Helium exploration.

Recently, the company executed an agreement with Holbrook Basin Energy LLC of Golden, CO to undertake an exploration drill program in Arizona. The Arizona project location is in the “Four Corners” area where the States of Utah, Colorado, New Mexico and Arizona meet, and in the helium productive Holbrook Basin, a well-established helium production district where concentrations of the gas are as high as 10%. The area has good potential for additional discovery and production. The abundant nature of the region has led to anecdotal statements over the years that “Arizona is the Saudi Arabia of helium.”

The Company holds 100 percent working interest and 87.5 percent net revenue interest in 12 federal leases at its Bruin Point property spanning across 17,000 acres in the Greater Uintah Basin, Carbon County, Utah (the Carbon County project). American Helium is undertaking preparations for the drilling of an exploration well, and as part of that process a Notice of Staking (NOS) has been filed with the offices of the Bureau of Land Management (BLM).

Evaluation is currently ongoing to determine potential additional acquisitions in regions that are known for their helium production. The Company is planning exploration wells with the prospect of capturing new resources and improving the Company’s market position during the year.

The Company has also executed a project agreement with Yankee Resources LLC of Golden, CO and has appointed LoneTree Energy & Associates LLC to acquire certain acreage in SE Colorado. The project consists of two parts. The first objective is to re-drill two wells that have proven helium resources. Both were plugged and abandoned in the mid-nineties, offering the potential for near term production. The second part of the project will offer an exploration focus through the acquisition of land and a subsequent 3D seismic survey aimed at further defining areas of likely helium accumulations.

The company set up a Denver satellite office aimed at overseeing the regional operations in Utah better and at facilitating expansion in SE Colorado. Company President and CEO Frank Jacobs, a petroleum engineer with 35+ years of operational experience, will oversee U.S.-based operations.

Global helium demand is driven by a number of different industries. Primarily, the military, healthcare, nuclear, aviation and electronics. A colorless, odorless and non-toxic gas, helium is lighter than air and it has the lowest boiling point of all elements. This property makes it essential for a wide variety of tech based applications.

The U.S. ranks as the largest producer and consumer of helium. North America accounts for approximately a third of the world’s helium consumption (2.6 billion cubic feet of helium per year). The world’s annual consumption of helium is set at eight billion cubic feet per year. As far as production goes, the U.S. is responsible for 55 percent of the global helium supply. Qatar, Algeria and Russia come next.

The fact that production efforts have been centralized and focused in just a few countries has long been a source of industry concern. “The concentration of production among a handful of countries will continue to be the leading driver of uncertainty of helium supply and price volatility. We are working to identify, explore and place into production helium assets. With the right assets and the necessary funding we are confident we can achieve this objective,” Frank Jacobs said.

The price of helium has doubled since 2010 because this unique gas cannot be substituted in its applications. In addition, a Qatar production blockage has had a massive negative impact on the helium supply. In the summer of 2017, Qatar’s RasGas closed down both of its plants, responsible for approximately 32 percent of the global helium demand. This shift has contributed to highly favorable supply and demand fundamentals for the remaining market players.

Experts predict that the demand for the gas will continue to grow in the years to come. The global helium market set to exceed $1.5 billion by 2020, advancing at a compound annual growth rate of 9 percent, according to Technavio analysts. Over 20 percent of the global helium demand is for healthcare applications. MRI machines are being installed in hospitals more frequently than ever before, potentially increasing the demand for helium in the medical industry. Innovative aerospace projects and technical applications are also expected to elevate the helium market forecasts in the years to come. Large corporations such as Google and Netflix have both been buying up significant amounts of helium, as the gas can increase the storage capacity of hard drives while also bringing down power consumption.

Additional information about the American Helium research and exploration activities will become available in the months to come. The company is positioning itself to capture the numerous opportunities stemming from increasing helium prices and the growing global demand.

For more information, visit the company’s website at www.AmeriHelium.com

• ETST is in the process of trademarking and finalizing packaging for a medical device designed to detect sexually transmitted infections
• The biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol (CBD)
• ETST is bringing to market non-invasive medical devices and vaccines for women; in vitro testing on the impact of its CBD formula on breast cancer cells to begin in summer of 2019

Earth Science Tech, Inc. (OTC: ETST), through its Earth Science Pharmaceutical subsidiary, is finalizing plans to launch global marketing and sales of its MSN-2 home testing medical kit for the detection of sexually transmitted infections (STI) in women. ETST plans to market it in such far-flung countries as Vietnam and Morocco (http://ibn.fm/fILCz).

ETST, a biotech company based in Doral, Florida, has repositioned its line of full spectrum CBD. As it conducts R&D for non-invasive medical devices, it is also focused on manufacturing, marketing and distributing its own cannabinoid products, including capsules and oils, to the nutraceutical and pharmaceutical markets.

The company’s MSN-2 medical device is in its final stage prior to the launch of large scale marketing. ETST is working with Acceleration, Design et Innovation Inc. Final packaging is being designed to appeal worldwide to its target audience of women. The device is developed to detect chlamydia and other STIs. It is a home kit that collects human cells which are then laboratory tested (http://ibn.fm/ATMSH).

In a news release, Dr. Michel Aube, CEO and chief science officer of ETST, stated, “We will create a strong demand for this medical device by showing the world its powerful capacity to diminish the prevalence of chlamydia and other sexually transmitted infections.” He noted that ETST is in the process of obtaining trademark protection for its logo and name.

In addition, funded by a grant from Quebec, Canada, ETST is now prototyping three CBD patent formulas. In vitro testing will begin on the first batch of formulas in the summer of 2019 to show the superior antioxidant properties and anti-proliferative effects on breast cancer cells. The branding of these products is in the planning stage.

ETST holds several wholly-owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit and accepts grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also has subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company formed to provide ETST with access to government grants.

For more information, visit the company’s website at www.EarthScienceTech.com

• Inquiries for EVIO’s cannabis testing services have skyrocketed since California’s regulatory changes were announced
• EVIO is poised to be a cannabis testing leader in California and is prepared to meet the increased demand for testing services
• New EVIO cannabis testing facilities are on track to open in Los Angeles and Humboldt County, California, by fall 2018

California cannabis vendors and distributors have been scrambling to make the July 1 deadline set forth by the California state government, mandating that all products found on marijuana dispensary shelves after that date must meet new testing standards relating to pesticides and residual solvents found in cannabis products. Under the new regulations, any untested or non-compliant cannabis products can no longer be sold by retailers; instead, they must either be destroyed or returned to distributors. Violators not in compliance after the deadline could face fines and other penalties.

While cannabis merchants and distributors have been sweating the deadline, leading cannabis testing provider EVIO Inc. (OTCQB: EVIO) has been as cool as a cucumber, having prepared for months for the impending changes and to accommodate the increased demand for cannabis testing services that’s sure to accompany them (http://ibn.fm/LBUE5).

A flood of inquiries has inundated EVIO since the changes were announced, with high-profile cannabis distributors from across the Golden State contacting the company about its state-of-the-art cannabis testing services. The overall number of potential clients with whom EVIO has been discussing contracts has skyrocketed.

Through its EVIO Labs division, EVIO provides cutting-edge accredited cannabis testing and analysis services, as well as scientific research and a full array of consulting services, for the regulated cannabis industry, helping its clients meet state regulatory mandates and be prepared for success in every area of their business. EVIO’s overarching aim is to ensure the safety and quality of the cannabis supply in the United States.

In the past, EVIO’s California facilities were testing cannabis products for 21 pesticides. Now, in keeping with the new regulations, the company will test for 66 pesticides.

The company’s EVIO Labs Berkeley just recently attained ISO 17025 accreditation, which is the world’s highest recognized quality standard for calibration and testing laboratories, and it is ready to perform California’s July 1st new testing regulations.

EVIO has also been working to expand its overall footprint in California. In May, the company signed a lease for a 2,700-square-foot facility in Los Angeles, and EVIO also acquired Leaf Detective, LLC, in April, which was the very first licensed cannabis testing facility in Humboldt County, California. The strategic acquisition of Leaf Detective gave EVIO a foothold within the “Emerald Triangle,” which is the biggest cannabis-producing region in the U.S. The Los Angeles and Humboldt County facilities are scheduled to open in the fall of 2018, and EVIO plans to further expand its operational growth in California and to add more personnel going forward.

EVIO is well-positioned to become a standout leader in the independent cannabis testing laboratory space, and, as California’s July 1 deadline looms, the company is unquestionably poised to take a leadership position in that state.

In other developments, EVIO recently announced the addition of technology industry expert Donald R. Gibbs, CPA, CMA, to its board of directors to serve as independent director and chair of the company’s audit committee (http://ibn.fm/f0HYX).

For more information, visit the company’s website at www.EVIOLabs.com

• Decision to legalize sports betting at state levels should expand opportunities in the legalized gambling industry
• Capable of servicing a broad range of vertical markets in the fintech space
• E-commerce estimated to reach $4.058 trillion in 2020

A new Supreme Court ruling could lead to state sanctioned gambling on college and professional sports, removing the decision from federal oversight. This is a welcome change in the gaming industry, as polls show that the majority of Americans support legalized sports betting. An estimated 15 million Americans actively participate in illegal betting according to a report by the gaming industry (http://ibn.fm/XMM0a). Since fans and sports organizations love data analytics, this trend, and the potential legalization of betting, gives those within the gaming industry an exciting opportunity. With illegal sports betting in the United States estimated at $150 billion, according to the American Gaming Association (http://ibn.fm/Sr4LW), Consorteum Holdings, Inc. (OTC: CSRH) is positioned for growth with its revolutionary predictive analytics platform and the legalization of the industry.

CSRH is a software development and mobile publishing company, with its primary focus in the mobile gaming sector. The company plans to release its first global sports app in 2018, offering massive amounts of compiled historical data and updates on cricket teams and players. With 2.5 billion worldwide cricket fans, this first predictive data analytics mobile offering will provide CSRH with an excellent position as it enters the gaming sector.

The cricket analytical tool is only one example of the application of CSRH’s state-of-the-art Universal Mobile Interface™ (UMI). The UMI platform is unique and flexible for clients’ needs and is capable of delivering and managing complex, digitally secure transactions. The company’s distribution strategy includes an array of license agreements and joint venture strategic agreements. CSRH management has spent the last several years developing relationships that will enable it to participate in the rapidly developing fintech market and its associated verticals.

The mobile gaming industry is not the only growing market vertical in which CSRH has an advantage due to its revolutionary UMI platform. E-commerce has been on a steady rise, expanding into existing markets such as grocery, personal care and apparel, and it is estimated to reach $4.058 trillion in 2020 (http://ibn.fm/XX53B). Retailers are working to capitalize on this growth by creating easy-to-use mobile applications. CSRH is uniquely positioned to make this a reality for retailers. Specializing in the delivery of complex mobile solutions and mobile payment solutions, the company is positioned to approach many different markets in the business of providing mobile connectivity, secure transactional processing and social connectivity. The rise of e-commerce is good news for CSRH.

For more information, visit the company’s website at www.Consorteum.com

• The company is working to increase the speed of transactions involving cryptocurrencies
• Its new point-of-sale terminals offer an easy-to-use payment experience that can be completed in mere seconds
• The cryptocurrency ATM and transaction market is expected to grow at a CAGR of 45.8 percent through 2025, with the global point-of-sale terminals market expected to reach $116.06 billion by 2025

Virtual Crypto Technologies Inc. (OTCQB: VRCP), an Israel-based technology company whose main goal is to make cryptocurrencies more available to the general public through PCs, tablets, mobile applications, ATMs and other devices, has announced an upgrade to its cryptocurrency point-of-sale terminals. In addition, Virtual Cryptocurrency Technologies has updated its NetoBit application – a real-time algorithmic technology capable of confirming the purchase and sale of cryptocurrency, according to a company press release (http://ibn.fm/4aK2r).

The new point-of-sale terminal offers a unique cashier-client experience with its two-way screen leveraging payment usage with which most customers are already familiar. Email addresses and similar types of information are no longer required for the transaction to be completed. This shortens the payment flow to seconds and makes it less complex. An app generates a QR code that has to be scanned for a transaction to take place.

On-site control for operators has also been enhanced, giving operators the option of enabling and disabling functionalities directly. It’s up to the operator to determine whether cash deposits and withdrawals will be enabled or if the point-of-sale terminal will solely allow for payments to be made.

The installation of the pilot program took place at Israel’s Lincoln Billiards Club at the beginning of June. According to Virtual Cryptocurrency Technologies CEO Alon Dayan, the new point-of-sale terminals provide a traditional process that increases the usability and approachability of cryptocurrencies. The initial response has been very positive, Dayan concluded.

Virtual Cryptocurrency Technologies has proven its adaptability when it comes to the rapid developments and the degree of uncertainty in the field of cryptocurrencies. NetoBit is one example of just how adaptable the company is in terms of meeting new regulatory frameworks and ensuring compliance. NetoBit’s software, utilized with a proprietary transaction validation algorithm, provides real-time information about cryptocurrency value at the time when a transaction takes place. The predictive algorithm is characterized by a high degree of accuracy when it comes to determining whether a cryptocurrency transaction is going to be approved immediately. As a result, NetoBit is capable of executing a zero-confirmation transaction, and the typical transaction time is reduced from up to 24 hours to just a few seconds.

The NetoBit ATM that was presented at TechCrunch in Tel Aviv enables real-time bitcoin conversions – the first for real-time sell/withdraw – enabling immediate sell transactions. Predictive analytical data and machine learning come into play here, increasing accuracy and solving one of the problems that the sector has had in terms of transaction validations and immediacy (http://ibn.fm/fhSFi).

Through its adaptability, Virtual Crypto Technology can be expected to strengthen its market position significantly. The demand for cryptocurrency ATMs and point-of-sale terminals has been increasing over the past few years in the context of a significant segment of the global population (roughly two billion) being unbanked but in need of financial services.

The number of cryptocurrency ATMs has increased exponentially over the last couple of years, from 502 in January 2016 to 2,662 ATMs worldwide in April 2018 (http://ibn.fm/nLspx). Almost of all of these support bitcoin transactions, but only about half support other types of cryptocurrencies, such as ehtereum or litecoin (http://ibn.fm/TcF11).

The cryptocurrency ATM market is expected to grow at a CAGR of 45.8 percent through 2025, reaching over $285 million (http://ibn.fm/HC9nU). While the popularity of cryptocurrencies is growing, there have been things standing in the way of mass adoption. Transaction speed was one of the issues, something that Virtual Crypto has now successfully addressed with zero confirmation.

For more information, visit the company’s website at www.Virtual-Crypto.com

• POC devices speed up triage, diagnosis and treatment of patients
• MIDS Cardiac™ is being developed to detect the biomarker troponin I or T for suspected heart attack within 3 minutes, as opposed to often taking 60 minutes in central laboratories
• Global cardiac biomarkers market expected to reach $13.3 billion by 2024

A recent report by Grand View Research analyzes the shortage of skilled medical staff and how this is expected to accelerate the market penetration rate of point-of-care (POC) diagnostic products (http://ibn.fm/6Yb2x). The major advantage of these devices is that they can be operated by both qualified medical professionals and non-medical personnel with minimal training. Through its joint venture ownership of MIDS Medical Limited (MML), Zenosense, Inc. (OTC: ZENO) is developing “MIDS”, a nano-magnetic detection technology to allow true laboratory accuracy at the POC. This groundbreaking technology, if successfully embodied in a POC device, strongly positions Zenosense to capitalize on the predicted global growth in this market.

In the United States, development funding for diagnostics is being provided by many institutions, including the National Institutes of Health (NIH), the Department of Defense (DOD) and private foundations such as the Bill and Melinda Gates Foundation.

MIDS development is carried out at MML’s laboratories at the Sci-Tech Daresbury campus in the UK, a facility that’s internationally recognized for leading-edge scientific research and commercial development. MML has exclusive rights to the MIDS technology platform through patents already granted in China and the United States. The company has also filed patent applications in all other key geographic areas around the world.

The MIDS technology uses nano-magnets to detect and quantify assay beads instead of the conventional optical detection method, with the MIDS “Lab-on-Chip” technology designed as an equally accurate, cost effective and much faster alternative to laboratory analysis.

POC devices have the capability to expedite laboratory testing, saving medical personnel crucial time in time-sensitive situations. MML is currently focused on the initial development and commercialization of its MIDS Cardiac POC technology. This project aims to deliver a handheld device using a disposable test strip for rapid detection of suspected heart attack, or acute myocardial infarction (AMI).

MIDS Cardiac is being developed for use by minimally trained emergency response personnel to speed up triage, diagnosis and treatment of patients suffering suspected symptoms of this life threatening condition. The technology aims to detect extremely low levels of cardiac biomarkers, including troponin, the medical profession’s biomarker of choice for AMI.

Currently, high sensitivity troponin assays can only be conducted in central laboratories using expensive equipment, and they typically take 60 minutes to turn around results. MML’s solution is being developed to be cost-effective, with the ability to produce troponin results within three minutes and more extensive biomarker testing expected to be provided within eight minutes.

Zenosense, through MML, intends to develop wider applications of its MIDS technology platform to include POC immunoassay testing of many other medical conditions and diseases. MML’s test results on its Hybrid Strip development system already indicate that MML can detect commercially available assay beads at extremely low levels. The successful incorporation of magnetic detection should provide a significant improvement in accuracy over existing POC devices that are limited to imperfect optical detection, which cannot equal laboratory analyzer performance.

The system uniquely positions Zenosense to capitalize on a fast-growing market. According to Grand View Research, the global cardiac biomarkers market is expected to reach $13.3 billion by 2024, and Markets and Markets report that the global immunoassay testing market is projected to be worth $25.45 billion by 2021.

For more information, visit the company’s website at www.Zenosense.com